期刊文献+

调节性T细胞与老年性骨质疏松的关系 被引量:2

The Relationship of Regulatory T Cells and Senile Osteoporosis
下载PDF
导出
摘要 目的检测不同年龄组雄性SD大鼠血调节性T细胞(Treg)数量占CD4+T细胞百分比,了解Treg细胞对老年性骨质疏松症的影响.方法选取6-8周龄、6月龄、12月龄、24月龄雄性SD大鼠每组各10只作为研究对象,采用双能X线吸收仪(DEXA)检测大鼠股骨、脊柱、骨盆、全身的骨密度;大鼠心脏采血,采用CD25+联合Fox P3+表达来描述Treg细胞,流式细胞仪测定血Treg数量占CD4+T细胞的百分比.结果 (1)6-8周龄组、6月龄组、12月龄组、24月龄组Treg数量不同,差异有统计学意义(P〈0.01).6-8周龄组Treg数量百分比低于6月龄组、12月龄组、24月龄组,差异有统计学意义(P〈0.01);6月龄组Treg数量百分比低于12月龄组、24月龄组(P〈0.05);24月龄组Treg数量百分比低于12月龄组比较,但差异无统计学意义(P〉0.05).(2)Treg数量占CD4+T细胞百分比与股骨、脊柱、骨盆、全身骨密度值均成正相关,差异均有统计学意义(P〈0.01).结论 (1)6-8周龄组、6月龄组、12月龄组、24月龄组Treg数量占CD4+T细胞百分比不同,6-8周龄时最低,6月龄时开始升高,12月龄时达到最高值,24月龄时出现下降,提示不同年龄组大鼠Treg数量占CD4+T细胞有明显差异(P〈0.05).(2)Treg数量占CD4+T细胞百分比与检测部位骨密度值呈正相关性,提示随着Treg数量百分比的增高,骨吸收减少,骨密度值升高,随着Treg数量百分比的降低,骨密度降低,鉴于随着年龄的增长,Treg数量出现下降,推测外源性注射Treg可抑制破骨细胞性骨吸收,可成为治疗老年性骨质疏松的新方向. Objective To understand the effect of regulatory T cells on senile osteoporosis by measuring the percentage of regulatory T cells in CD4+T cells in different age groups of male SD rats. Me thods Sprague- Dawley male rats which was 6- 8 weeks,6 months,12 months,24 months old were selected as subjects. There were 10 rats in each group. We detected bone mineral density of femur, spine, pelvis, whole- body of rats by dual- energy X- ray absorptiometry. We collected blood samples from the heart, used CD25/forkhead box P3 double- positive to describe regulatory T cells and then measured the percentage of regulatory T cells in CD4+T cells by flow cytometry.Re s ults(1) The percentage of regulatory T cells in CD4+T cells in 6- 8 weeks,6 months,12 months,24 months old male rats groups were not the same, the difference was statistically significant(P=0.000). The percentage of regulatory T cells in CD4+T cells of 6- 8weeks old groups was lower than 6 months, 12 months, 24 months old groups, the difference was statistically significant(P =0.000). The percentage of regulatory T cells in CD4+T cells of 6 months old groups was lower than 12 months, 24 months old groups, the difference was statistically significant(P〈0.05). The percentage of regulatory T cells in CD4+T cells of 24 months old groups was lower than12 months, but there was no significant difference(P〈0.05).(2) There was a positively correlation between the percentage of regulatory T cells in CD4+T cells and bone mineral density of femur, spine, pelvis, whole- body.Conclus ions(1) The percentage of regulatory T cells in CD4+T cells in four groups are not the same,the lowest at 6- 8 weeks of age,by 6 months,there is an increase and when 12 months increase to a maximum then decrease at24 months of age, indicating that the percentage of regulatory T cells in CD4+T cells in different age groups are significantly different.(2) There is a positive correlation between the percentage of regulatory T cells in CD4+T cells and bone mineral density of femur,spine,pelvis,whole- body,indicating that because of the bone resorption reducing with the percentage of regulatory T cells increasing,the values of bone mineral density raising,when the percentage of regulatory T cells decreasing, the values of bone mineral density declining. In view of the number of regulatory T cells declining with aging,suggesting that exogenous injection of regulatory T cells may inhibit the bone resorption by osteoclast,which may become the new direction of senile osteoporosis treatment.
出处 《昆明医科大学学报》 CAS 2016年第4期87-90,共4页 Journal of Kunming Medical University
基金 云南省卫生厅内设研究机构科技计划项目(2012ws0031)
关键词 骨质疏松症 调节性T细胞 老年 Osteoporosis Regulatory T cells Aging
  • 相关文献

参考文献20

  • 1COMPSTON J. Guidelines for the management of osteoporosis: the present and the future [J]. Osteoporos Int,2005,16(10):1173-1176.
  • 2COLE Z A,DENNISON E M,COOPER C. Osteoporosis epidemiology update [J]. Curr Rheumatol Rep,2008,10(2):92-96.
  • 3徐玉善,江艳,李少遊,李红,洪敏,李文艳,包秋燕.绝经后骨质疏松症的T细胞亚群的变化及意义[J].昆明医科大学学报,2015,36(4):34-36. 被引量:7
  • 4LISTON A,GRAY D H. Homeostatic control of regulatory T cell diversity [J]. Nat Rev Immunol,2014,14(3):154-165.
  • 5SAKAGUCHI S,REGULATORY T. Cells: key controllers of immunologic self-tolerance [J]. Cell,2000,101(5):455-458.
  • 6LI X,LIANG Y,LEBLANC M,et al. Function of a Foxp3 cis-element in protecting regulatory T cell identity [J]. Cell,2014,158(4):734-748.
  • 7SON H J,LEE J,LEE S Y, et al. Metformin attenuates experimental autoimmune arthritis through reciprocal regulation o?Thl7/Treg balance and osteoclastogenesis[J]. Mediators Inflamm,2014,2014N:973986.
  • 8张立智,蒋垚.骨免疫学研究进展[J].国际骨科学杂志,2009,30(4):218-220. 被引量:14
  • 9PARK J S, KWOK S K,LIM M A,et al.STA-21,a promising STAT-3 inhibitor that reciprocally regulates Th 17 and Treg cells, inhibits osteoclastogenesis in mice and humans and alleviates autoimmune inflammation in an experimental model of rheumatoid arthritis [J]. Arthritis Rheumatol,2014,66(4):918-929.
  • 10ZAISS M M,FREY B,HESS A,et al. Regulatory T cells protect from local and systemic bone destruction in arthritis [J]. J Immunol,2010,184(12):7238-7246.

二级参考文献10

  • 1何勇,刘树琴,王长江,贾敬华,王佑民,章秋,潘天荣.IL-6、TNF-α在绝经后骨质疏松症发生中的作用[J].中国临床保健杂志,2007,10(1):41-43. 被引量:19
  • 2E. Pérez,O. García-Martínez,M. Arroyo-Morales,C. Reyes-Botella,C. Ruiz. Modulation of Antigenic Phenotype in Cultured Human Osteoblast-like Cells by FGFb, TGFβ1, PDGF-BB, IL-2, IL-1β, LPS and IFNγ[J] 2006,Bioscience Reports(4):281~289
  • 3OKAMOTO K,TAKAYANAGI H. Regulation of bone by the adaptive immune system in arthritis [J]. Arthritis Res]'her, 2011,13(3 ):219.
  • 4ISLANDER U ,JOCHEMS C ,LAGERQUIST M K,et al. E- strogens in rheumatoid arthritis; the immune system and bone[ J ]. Mol Cell Endocrinol, 201 I, 335( I ): 14-29.
  • 5MARUOTYI N, GRANO M,COLUCCI S,et al. Osteoclas- togenesis and arthritis [J]. Clin Exp Med,2011,11 (3): 137- 145.
  • 6COMPSTON J. Guideline for the management of osteo- porosis:the present and the future [J]. Osteoporos Int, 2005,16( 16): 1 173-1 176.
  • 7VAN GEEL T A, NGUYEN N D, GEUSENS P P,et al. De- velopment of a simple prognostic nomogram for individual- ising 5-year and lO-year absolute risks of fracture: a popu- lation-based prospective study among postmenopausal women[J]. Ann Rheum Dis,2011,1(70):92-97.
  • 8HICKEY M,AMBEKAR M, HAMMOND I. Should the o- varies be removed or retained at the time of hysterectomy for benign disease [J]. Hum Reprod Update,2010,2 (16): 131-141.
  • 9DANKS L,TAKAYANAGI H. Immunology and bone EJ]. J Biochem,2013,154(1 ):29-39.
  • 10KOMANO Y, NANKI T, HAYASHIDA K, et al.ldentifica- tion of a human peripheral blood monocyte subset that dif- ferentiates into osteoclasts [ J ]. Arthritis Res Ther, 2006,8 (5):R152.

共引文献18

同被引文献17

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部